QLI: Qilian International Company Buyout Price

Brandmark of Qilian International (QLI)

Qilian International (QLI) is implementing advanced purification methods for chemical raw materials and plant components. The current R&D cycle is characterized by a lack of radical breakthroughs and a focus on quality control automation. The business generates revenue from the sale of heparin, herbal extracts, and fertilizers through wholesale channels and its own pharmacies. The Enterprise Value stands at , as clearly demonstrated by the current stock price action on this chart.

QLI Qilian International Holding Group: Enterprise Value in the range 07/04/2022 - 10/29/2026
Manufactured products of qlsyy.net

This indicator determines the theoretical cost of a full business buyout by summing market capitalization and net debt to reveal the asset's real price. By analyzing the total capital level, an investor assesses the financial stability of Qilian International (QLI), whose local reputation as an organic producer in China contrasts with the speculative nature of trading due to its limited international presence.

Who Qilian International competes with

Total Company Value Haleon PLC HLN|Enterprise Value KVUE (Kenvue Corp)|VRNA: Company Buyout Price|Total Company Value Jyong Biotech Ltd (MENS)|ligand.com (LGND) - Full Business Value|AMRX - Enterprise Value|Value Adjusted for Debt and Cash Perrigo Company PLC|Enterprise Value ALVO|Enterprise Value LQDA (Liquidia Inc.)|Total Company Value Galapagos NV|anipharmaceuticals.com - Value Adjusted for Debt and Cash|MNKD: Total Company Value|AMPH - Real Price to Acquire Entire Company|PCRX: Enterprise Value|Enterprise Value ARS Corp|TBPH - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash AQST|scPharmaceuticals Inc. - Total Company Value|Total Enterprise Value tectonictx.com TECX|Real Price to Acquire Entire Company Tonix Pharmaceuticals Inc. (TNXP)|Aggregate Business Value SXT Pharmaceuticals SXTC|Enterprise Value Eupraxia Pharma (EPRX)|BHST - Value Adjusted for Debt and Cash|Enterprise Value EXOZ|ORMP (Oramed Pharmaceuticals Inc.) - Total Enterprise Value|ENTX - Total Company Value|Value Adjusted for Debt and Cash HYFT|ABVC: Total Company Value|Full Takeover Company Value cumberlandpharma.com (CPIX)|Enterprise Value QNTM|FibroGen Inc - Company Buyout Price|TELO - Total Company Value|RANI - Total Company Value|synergychc.com - Enterprise Value|Rallybio (RLYB) - Company Buyout Price|LEXX (Lexaria Bioscience Corp) - Enterprise Value|Enterprise Value PULM|Total Company Value Pheton Holdings Ltd PTHL|Business Value aptorumgroup.com APM|Real Price to Acquire Entire Company Lyra Therapeutics, Inc.|Value Adjusted for Debt and Cash Impact BioMedical, Inc. IBO|Enterprise Value TNFA (TNF Pharma)|YCBD: Company Buyout Price|Total Company Value PainReform Limited|Business Value Altamira Therapeutics Ltd.|Lipella Pharmaceuticals (LIPO) - Real Price to Acquire Entire Company|Aggregate Business Value optinose.com|Pieris Pharmaceuticals, Inc. - Enterprise Value|Total Enterprise Value PROC (Procaps Group)|Total Company Value Petros|ACELYRIN Inc. - Value Adjusted for Debt and Cash|TFF Pharmaceuticals (TFFP) - Total Company Value